Diamyd Medical AB (publ)

Diamyd Medical AB (publ)verified

DMYD-B.ST

Price:

$9.82

Market Cap:

$1.32B

Diamyd Medical AB (publ) develops therapies for the treatment of autoimmune diabetes. The company develops Diamyd, an antigen-specific immunotherapy diabetes vaccine, which is in phase IIb clinical trial for the treatment of type 1 diabetes and latent autoimmune diabetes; and Remygen, an oral regenerative and immunomodulatory drug candidate, which is in phase I/II clinical trial for the treatment of autoimmune and type 2 diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB (publ) in April 2013. Diamyd Medical AB (publ) was incorporated in 1984 and is based in Stockholm, Sweden.

Industry

Biotechnology

IPO Date

2013-05-20

Stock Exchange

STO

Ticker

DMYD-B.ST

The PE Ratio as of December 2025 (TTM) for Diamyd Medical AB (publ) (DMYD-B.ST) is -6.55

According to Diamyd Medical AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -6.55. This represents a change of -12.52% compared to the average of -7.49 of the last 4 quarters.

Diamyd Medical AB (publ) (DMYD-B.ST) Historical PE Ratio (quarterly & annually)

How has DMYD-B.ST PE Ratio performed in the past?

The mean historical PE Ratio of Diamyd Medical AB (publ) over the last ten years is 25.68. The current -6.55 PE Ratio has changed -2650.37% with respect to the historical average. Over the past ten years (40 quarters), DMYD-B.ST's PE Ratio was at its highest in in the February 2021 quarter at 36.34. The PE Ratio was at its lowest in in the August 2020 quarter at -52.20.

Quarterly (TTM)
Annual

Average

25.68

Median

-7.26

Minimum

-15.22

Maximum

288.59

Diamyd Medical AB (publ) (DMYD-B.ST) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Diamyd Medical AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 141.49%

Maximum Annual PE Ratio = 288.59

Minimum Annual Increase = -1996.03%

Minimum Annual PE Ratio = -15.22

Quarterly (TTM)
Annual
YearPE RatioChange
2025-7.91-23.09%
2024-10.2955.83%
2023-6.60-40.19%
2022-11.04-128.18%
202139.17-86.43%
2020288.59-1996.03%
2019-15.2250.71%
2018-10.10141.49%
2017-4.18-25.13%
2016-5.59-35.71%

Diamyd Medical AB (publ) (DMYD-B.ST) Average PE Ratio

How has DMYD-B.ST PE Ratio performed in the past?

The current PE Ratio of Diamyd Medical AB (publ) (DMYD-B.ST) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-8.27

5-year avg

0.66

10-year avg

25.68

Diamyd Medical AB (publ) (DMYD-B.ST) PE Ratio vs. Peers

How is DMYD-B.ST’s PE Ratio compared to its peers?

Diamyd Medical AB (publ)’s PE Ratio is less than Oncopeptides AB (publ) (-3.97), greater than SynAct Pharma AB (-10.16), less than Genovis AB (publ.) (63.92), less than BICO Group AB (publ) (-6.17), less than Cantargia AB (publ) (7.35), less than Xspray Pharma AB (publ) (-5.22), greater than OssDsign AB (publ) (-30.47), greater than Infant Bacterial Therapeutics AB (publ) (-8.09), less than Egetis Therapeutics AB (publ) (-5.53), less than BioInvent International AB (publ) (-5.88),

Build a custom stock screener for Diamyd Medical AB (publ) (DMYD-B.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Diamyd Medical AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Diamyd Medical AB (publ) (DMYD-B.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Diamyd Medical AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Diamyd Medical AB (publ)'s PE Ratio?

How is the PE Ratio calculated for Diamyd Medical AB (publ) (DMYD-B.ST)?

What is the highest PE Ratio for Diamyd Medical AB (publ) (DMYD-B.ST)?

What is the 3-year average PE Ratio for Diamyd Medical AB (publ) (DMYD-B.ST)?

What is the 5-year average PE Ratio for Diamyd Medical AB (publ) (DMYD-B.ST)?

How does the current PE Ratio for Diamyd Medical AB (publ) (DMYD-B.ST) compare to its historical average?